Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
When do you target the thalamus for SEEG exploration or neuromodulation in patients with drug-resistant epilepsy?
Related Questions
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
What are your preferred anti-seizure medications in Doose syndrome?
When do you use seizure prophylaxis in patients on clozapine?
How significant are the cardiovascular side effects, such as hypertension, associated with valproate?
What recommendations would you make for a patient on long-term phenytoin due to epilepsy with a newly diagnosed breast cancer requiring doxorubicin as part of her chemotherapy?
When would you consider using vigabatrin as part of treatment for status epilepticus?
Would you use bupropion for mood disorder or substance use in an adult patient with previous childhood seizures that resolved?
When do you attribute tremors to lamotrigine?
Does valproic acid or lithium use in the egg donor pose a risk to the fetus in a surrogate pregnancy?
When, if ever, would you pursue genetic testing in an asymptomatic child with multiple first-degree relatives with epilepsy?
